OCGN Competitors & Alternatives
Compare Ocugen Inc with similar stocks in the same industry
Biotechnology
OCGN
Main Stock$1.51
Tradestie Score
48
Market Cap
$524.67M
Revenue Growth
0.5%
Analyst Upside
+666.3%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$2.00
|
$512.39M | - | 57 | Compare |
|
RGNX
REGENXBIO Inc.
|
$10.55
|
$493.52M | - | 59 | Compare |
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$134.35
|
$492.21M | - | 60 | Compare |
|
XOMA
XOMA Royalty Corporation Common Stock
|
$41.89
|
$474.20M | 28.3 | 57 | Compare |
|
ABSI
Absci Corporation Common Stock
|
$5.90
|
$468.01M | - | 54 | Compare |
|
GLUE
Monte Rosa Therapeutics, Inc. Common Stock
|
$19.39
|
$463.20M | - | 59 | Compare |
|
SLDB
Solid Biosciences Inc. Common Stock
|
$7.27
|
$457.09M | - | 54 | Compare |
|
MRVI
Maravai LifeSciences Holdings, Inc. Class A Common Stock
|
$4.85
|
$454.29M | - | 59 | Compare |
|
RAPT
RAPT Therapeutics, Inc. Common Stock
|
$58.02
|
$450.49M | - | 53 | Compare |
|
MLTX
MoonLake Immunotherapeutics Class A Ordinary Shares
|
$17.06
|
$448.32M | - | 56 | Compare |
More OCGN Analysis
Data updated: May 10, 2026 | Industry: Biotechnology (SIC 2836)
230 stocks in this industry